Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A8GM
|
||||
Former ID |
DNCL003469
|
||||
Drug Name |
Ublituximab
|
||||
Synonyms |
TG-1101
|
||||
Drug Type |
Antibody
|
||||
Indication | Chronic lymphocytic leukaemia [ICD10:C91] | Phase 2 | [549929] | ||
Company |
TG Therapeutics
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | [533097] | ||
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.